Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users
Clinical trial NCT02682225 · COMPLETED
Trial details
- NCT number
- NCT02682225
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-25
- Primary completion
- 2017-01-09
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.